Loading...
Toxicity management of immunotherapy for patients with metastatic melanoma
Checkpoint inhibitors have revolutionized the treatment of patients with metastatic melanoma offering improved responses and significant survival benefit. These agents are now approved for the treatment of metastatic melanoma, squamous and non-squamous non-small cell lung cancer (NSCLC) and kidney c...
Saved in:
| Published in: | Ann Transl Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4971373/ https://ncbi.nlm.nih.gov/pubmed/27563659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.07.10 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|